Skip to content
DraconiticResearch
Search Sources API
203,203 studies31 sourcesUpdated 9 min ago
Peer-reviewedCC BY 4.0International Journal of Nephrology

Decoding Immune Dysregulation in Childhood Idiopathic Nephrotic Syndrome: Insights From Lymphocyte Subsets and Urinary Cytokine Analysis

  1. 1Department of Biochemistry AIIMS Bhubaneswar 751019 Odisha India aiims.edu
  2. 2Department of Pediatrics AIIMS Bhubaneswar 751019 Odisha India aiims.edu

Abstract

Background: Idiopathic nephrotic syndrome (INS) is a primary kidney disease of childhood involving podocytes where immune dysregulation is thought to play a major role in pathogenesis. The aim of the study was to evaluate peripheral lymphocyte subsets and urinary cytokines in children with INS to understand the immune mechanisms and their association with steroid responsiveness.

Methods: This was a prospective longitudinal observational study of children with INS, conducted at a tertiary care hospital from August 2021 to June 2023. A total of 34 children with INS (17 steroid sensitive [SSNS] and 17 steroid resistant [SRNS]) and 17 healthy controls were enrolled. Flow cytometry analyzed CD3+, CD4+, CD8+, and CD19+ lymphocyte subsets, while ELISA estimated urinary IFN‐γ, IL‐4, and IL‐13 at the onset of disease/relapse and during remission.

Results: Children with INS showed significantly higher counts of CD3+, CD4+, CD8+, and CD19+ cells compared to controls (p < 0.05) at the time of disease onset. SRNS patients had notably higher counts of all these subsets than SSNS patients. Following steroid therapy, CD19+ and CD3+ counts increased in both groups; however, SRNS patients also showed a persistent increase in CD4+ cells and urinary IFN‐γ and IL‐13, suggesting ongoing immune activation. ROC curve analysis identified CD3+, CD4+, and CD19+ counts with moderate diagnostic performance with AUC values ranging from 0.706 to 0.747.

Conclusion: Significant alterations in T‐ and B‐lymphocyte subset populations indicate immune activation in the pathogenesis of childhood INS. The distinct immunological profiles and poststeroid cytokine increases in SRNS patients indicate persistent local immune activation despite treatment.

Related

  1. Vascular Remodelling in Idiopathic Nephrotic Syndrome with Administration of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers
    H. Dimiati, S. Haris, K. Hasballah +1
    medRxivPreprintCC BYFull textGeneral medicinemedRxiv
  2. Acute Kidney Injury in Childhood Nephrotic Syndrome: From Hemodynamic Vulnerability and Tubular Stress Toward Biomarker-Guided Management.
    John Dotis, Nikoleta Printza
    Medicina (Kaunas, Lithuania)Peer-reviewedCC BYFull textGeneral medicineEurope PMC
  3. Intussusception as a rare cause of abdominal pain in a child with idiopathic nephrotic syndrome: a case report and review of literature
    A. S. Athapathu, A. K. Fathima Nisra, K. E. G. P. Padmasiri +2
    BMC PediatricsPeer-reviewedCC BYFull textSurgery & anaesthesiaDOAJ
  4. A Randomized Controlled Trial of Two Corticosteroid Dosages for Relapsed Childhood Steroid-Sensitive Nephrotic Syndrome: The OPtimising dosE in Nephrotic Syndrome (OPEN) Trial Protocol
    Nicholas G. Larkins, Hugh McCarthy, Simon A. Carter +20
    Kidney International ReportsPeer-reviewedCC BY 4.0Full textGeneral medicinePMC
  5. The Prognostic Value of Baseline Neutrophil-to-Lymphocyte Ratio for Mortality in Idiopathic Pulmonary Fibrosis: A Systematic Review and Meta-Analysis.
    Suprava Shakya, Xingxiang Xu
    CureusPeer-reviewedCC BYFull textOncologyEurope PMC
BibTeX
@article{ashok2026decoding,
  title = {{Decoding Immune Dysregulation in Childhood Idiopathic Nephrotic Syndrome: Insights From Lymphocyte Subsets and Urinary Cytokine Analysis}},
  author = {A. K. Anju Ashok and Gautom Kumar Saharia and Amit Kumar Satapathy and Manaswini Mangaraj},
  journal = {International Journal of Nephrology},
  year = {2026},
  month = nov,
  doi = {10.1155/ijne/3601660},
  url = {https://doi.org/10.1155/ijne/3601660},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Decoding Immune Dysregulation in Childhood Idiopathic Nephrotic Syndrome: Insights From Lymphocyte Subsets and Urinary Cytokine Analysis
AU  - A. K. Anju Ashok
AU  - Gautom Kumar Saharia
AU  - Amit Kumar Satapathy
AU  - Manaswini Mangaraj
PY  - 2026
DA  - 2026/11/04
JO  - International Journal of Nephrology
DO  - 10.1155/ijne/3601660
UR  - https://doi.org/10.1155/ijne/3601660
AB  - Background: Idiopathic nephrotic syndrome (INS) is a primary kidney disease of childhood involving podocytes where immune dysregulation is thought to play a major role in pathogenesis. The aim of the study was to evaluate peripheral lymphocyte subsets and urinary cytokines in children with INS to understand the immune mechanisms and their association with steroid responsiveness.  Methods: This was a prospective longitudinal observational study of children with INS, conducted at a tertiary care hospital from August 2021 to June 2023. A total of 34 children with INS (17 steroid sensitive [SSNS] and 17 steroid resistant [SRNS]) and 17 healthy controls were enrolled. Flow cytometry analyzed CD3+, CD4+, CD8+, and CD19+ lymphocyte subsets, while ELISA estimated urinary IFN‐γ, IL‐4, and IL‐13 at the onset of disease/relapse and during remission.  Results: Children with INS showed significantly higher counts of CD3+, CD4+, CD8+, and CD19+ cells compared to controls (p < 0.05) at the time of disease onset. SRNS patients had notably higher counts of all these subsets than SSNS patients. Following steroid therapy, CD19+ and CD3+ counts increased in both groups; however, SRNS patients also showed a persistent increase in CD4+ cells and urinary IFN‐γ and IL‐13, suggesting ongoing immune activation. ROC curve analysis identified CD3+, CD4+, and CD19+ counts with moderate diagnostic performance with AUC values ranging from 0.706 to 0.747.  Conclusion: Significant alterations in T‐ and B‐lymphocyte subset populations indicate immune activation in the pathogenesis of childhood INS. The distinct immunological profiles and poststeroid cytokine increases in SRNS patients indicate persistent local immune activation despite treatment.
SN  - 2090-214X
SN  - 2090-2158
ER  -